| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/11/2002 | US20020042364 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 04/11/2002 | US20020042149 Analyzing preferential particles in bodily fluid; obtain sample, incubate with binding particles, detect bound particles |
| 04/11/2002 | US20020042127 Genetically engineered aggregation for use in the treatment of cancer |
| 04/11/2002 | US20020042103 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 04/11/2002 | US20020042097 Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
| 04/11/2002 | US20020042089 Interleukin-5 specific recombinant antibodies |
| 04/11/2002 | US20020042087 Inducing preferential cell proliferation; obtain preferential cells, incubate with modulator, monitor cell sample for proliferation activity |
| 04/11/2002 | US20020042045 METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL HTLV-II nra ENVELOPE PEPTIDES |
| 04/11/2002 | US20020041900 Chondrocyte cultures and fractions therefrom |
| 04/11/2002 | US20020041882 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 04/11/2002 | US20020041877 Individualized anti-cancer antibodies |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | DE10043481A1 Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung Human antibodies against endoglin (CD105) and its use |
| 04/11/2002 | CA2426621A1 Drug resistance-associated gene and use thereof |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
| 04/11/2002 | CA2424834A1 Nogo receptor homologs |
| 04/11/2002 | CA2424749A1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | CA2424543A1 Component for vaccine |
| 04/11/2002 | CA2424296A1 Human anti-cd40 antibodies |
| 04/11/2002 | CA2424275A1 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2422214A1 Factor vii glycoforms |
| 04/10/2002 | EP1195439A2 Retroviral vector with heterologous sequences between the retroviral primer binding site and the retroviral splice donor site |
| 04/10/2002 | EP1195436A1 Expression vectors with modified ColE1 origin of replication for control of plasmid copy number |
| 04/10/2002 | EP1195433A2 Respiratory chain enzyme genes of coryneform bacteria |
| 04/10/2002 | EP1195384A1 Snake proteins having antithrombotic activity |
| 04/10/2002 | EP1194575A1 Modified human granulocyte-colony stimulating factor and process for producing same |
| 04/10/2002 | EP1194572A2 Promoter sequences derived from fusarium venenatum and uses thereof |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194563A1 Fimh adhesin-based vaccines |
| 04/10/2002 | EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194555A1 Methods for making apo-2 ligand using divalent metal ions |
| 04/10/2002 | EP1194551A1 G-protein coupled receptor and dna sequences thereof |
| 04/10/2002 | EP1194550A1 Antimicrobial peptides derived from molluscs |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194528A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/10/2002 | EP1194451A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 04/10/2002 | EP1194450A1 Inactivated vaccine against feline calicivirus disease |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194447A2 Novel potassium channels and genes encoding these potassium channels |
| 04/10/2002 | EP1194445A1 Methods for protein purification using aqueous two-phase extraction |
| 04/10/2002 | EP1194164A1 Prion protein peptides and uses thereof |
| 04/10/2002 | EP1194161A1 Stable factor viii compositions |
| 04/10/2002 | EP1178116A9 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 04/10/2002 | EP0850044B1 Process for obtaining amino acids from proteins and use of the amino-acid-containing products obtained |
| 04/10/2002 | EP0752876B1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 04/10/2002 | EP0694070B1 Recombinant alphavirus vectors |
| 04/10/2002 | EP0661990B1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 04/10/2002 | CN1344322A BASBO55 polynucleotide and polypeptide from neisseria meningitidis uses thereof |
| 04/10/2002 | CN1344320A Cytokine receptor zalphall |
| 04/10/2002 | CN1344318A Protein for blocking platelet adhesion |
| 04/10/2002 | CN1344317A 多肽 Polypeptide |
| 04/10/2002 | CN1344276A Antibodies and FV fragment recognizing antigen IORC2 |
| 04/10/2002 | CN1344275A Methods for amyloid removal using anti-amyloid antibodies |
| 04/10/2002 | CN1344169A Glycoconjugates obtained from i(candide Utilis) cells and i(Ricinus)i(communis) seeds |
| 04/10/2002 | CN1344138A Process for producing soybean protein hydrolyzate |
| 04/10/2002 | CN1343774A Coding sequence of epilepsia associated protein, polypeptide coded by it, and its preparing process and application |
| 04/10/2002 | CN1343726A Polypeptide-mouse myoglubulin I-111-18.48 and polynucleotide for coding it |
| 04/10/2002 | CN1343724A GDNF mutant and its medical application |
| 04/10/2002 | CN1343688A Human NIP2 associated protein and coding sequence and application thereof |
| 04/10/2002 | CN1082663C Immunoassay for analytes in samples of the patients, and medicine case |
| 04/09/2002 | US6369211 MAGE-3 peptides presented by HLA class II molecules |
| 04/09/2002 | US6369206 Metal organothiol particles |
| 04/09/2002 | US6369204 Receptor known to be expressed in large amounts on the surface of osteoclasts and associated with bone resorption; use treating osteoporosis and/or in the inhibition of tumor cell growth |
| 04/09/2002 | US6369203 Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 04/09/2002 | US6369202 Genes encoding LSIRF polypeptides |
| 04/09/2002 | US6369198 Signal transducer and activator of transcription (stat) proteins; |
| 04/09/2002 | US6369196 Molecules of the card-related protein family and uses thereof |
| 04/09/2002 | US6369045 Phospholipase A2 inhibitors thereof and use of same in diagnosis and therapy |
| 04/09/2002 | US6369029 Method of stimulating osteogenesis using a c-terminally truncated insulin-like growth factor binding protein-5 (IGFBP-5) |
| 04/09/2002 | US6369027 Osteoprotegerin |
| 04/09/2002 | US6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368839 Aldolase catalytic antibody |
| 04/09/2002 | US6368832 A polypeptide of a major capsid protein; diagnosis and therapy for skin cancer; vaccines |
| 04/09/2002 | US6368830 An amino acid sequence; for efficient and increased transposition in genetic engineering methods |
| 04/09/2002 | US6368829 An isolated nucleic acid encoding a polypeptide for a tumor suppressor gene; diagnosis and therapy for diseases |
| 04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 04/09/2002 | US6368812 Exposing transfected cells with dna or infected rna encoding a galanin receptor and a chemical that is a possible receptor activator; measure the receptor activity in the absence and presence of the chemical with the transfected cells |
| 04/09/2002 | US6368601 Isolated dna |
| 04/09/2002 | CA2128407C Synthetic peptides for a rubella vaccine |
| 04/09/2002 | CA2093219C Amides of antibiotic ge 2270 factors |
| 04/09/2002 | CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same |
| 04/09/2002 | CA2009306C Expression systems for amidating enzyme |
| 04/09/2002 | CA1341356C Transkaryotic implantation |
| 04/09/2002 | CA1341355C Production and use of il-6 |
| 04/06/2002 | CA2358239A1 Novel siglec-like gene |
| 04/04/2002 | WO2002027327A2 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |